ArticleProceedings of the National Academy of Sciences of the United States of America2021

AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylase.

Yohei Yoshihama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.